6 items3 sources7 stocks
Yahoo Finance / Benzinga-Nov 2, 06:11 AM
SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus - Yahoo Finance
SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus - Yahoo Finance(摘要待生成)
Yahoo Finance / Benzinga-Oct 30, 04:03 AM
Dow, S&P 500, Nasdaq Futures Fall As Weak Tech Earnings Trigger Selloff: INTC, IOVA, SLS, AMZN Stocks In Focus - Yahoo Finance
Dow, S&P 500, Nasdaq Futures Fall As Weak Tech Earnings Trigger Selloff: INTC, IOVA, SLS, AMZN Stocks In Focus - Yahoo Finance(摘要待生成)
Stocktwits-Nov 16, 09:50 AM
SLS Stock Surges After-Hours: Sellas Says 'Transformative' Phase 3 AML Results Are Coming This Month
SLS Stock Surges After-Hours: Sellas Says 'Transformative' Phase 3 AML Results Are Coming This Month Stocktwits
SLSequity_markets
Stocktwits-Oct 28, 04:13 PM
Sellas’ GPS Trial Records 80th Event — Retail Says ‘Completely Irrational Sell Off’ As SLS Stock Tanks 18%
Sellas’ GPS Trial Records 80th Event — Retail Says ‘Completely Irrational Sell Off’ As SLS Stock Tanks 18% Stocktwits
SLSequity_markets
Stablecoin Development / NYSE American statement, reported by TipRanks-Oct 28, 03:19 PM
SELLAS Life Sciences Stock (SLS) Slides 18% as a Phase 3 Study Enters Its Evaluation Period - TipRanks
SELLAS Life Sciences Stock (SLS) Slides 18% as a Phase 3 Study Enters Its Evaluation Period TipRanks
SLSequity_markets